US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist

71.160
+2.040+2.95%

Close Feb 28 16:00 ET

71.160
0.0000.00%

Post 20:01 ET

13.58BMarket Cap32.20P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical Q4 2024 Earnings Date

Currency：USDFeb 19, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	711.05M	747.31M	+36.27M
Beat Est.	+10.03%	+15.65%	+5.10%
EPS	0.51	0.64	+0.13
Beat Est.	+363.18%	+481.82%	+25.61%

Analyst Rating

Strong Buy

Feb 28, 2025

Biomarin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 768.026M	--
--	2025/Q1	-- / 741.095M	--
Feb 19, 2025	2024/Q4	747.313M / 711.046M	--
Oct 29, 2024	2024/Q3	745.740M / 703.312M	--
Aug 5, 2024	2024/Q2	712.029M / 664.008M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 768.026M--

--2025/Q1-- / 741.095M--

Feb 19, 20252024/Q4747.313M / 711.046M--

Oct 29, 20242024/Q3745.740M / 703.312M--

Aug 5, 20242024/Q2712.029M / 664.008M--

Unlock Free Earnings Estimates

Open Account

Biomarin Pharmaceutical Earnings Reports

Biomarin Pharmaceutical | 10-K: FY2024 Annual Report

Feb 24 13:58 ET

Biomarin Pharmaceutical | 8-K: BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance